In-vitro activity of monobactam, SQ 26,776, against Gram-negative bacteria.

Suppr

超能文献

作者信息

Percival A, Thomas E, Hart C A, Karayiannis P

出版信息

J Antimicrob Chemother. 1981 Dec;8 Suppl E:49-55. doi: 10.1093/jac/8.suppl_e.49.

DOI:10.1093/jac/8.suppl_e.49

PMID:6799482

Abstract

摘要

相似文献

In-vitro activity of monobactam, SQ 26,776, against Gram-negative bacteria.

J Antimicrob Chemother. 1981 Dec;8 Suppl E:49-55. doi: 10.1093/jac/8.suppl_e.49.

In-vitro activity of the monobactam, SQ 26,776, against Gram-negative bacteria and its stability to their beta-lactamases.

J Antimicrob Chemother. 1981 Dec;8 Suppl E:29-37. doi: 10.1093/jac/8.suppl_e.29.

Antibacterial activity of the monobactam SQ 26,776 against antibiotic resistant enterobacteria, including Serratia spp.

J Antimicrob Chemother. 1981 Dec;8 Suppl E:57-68. doi: 10.1093/jac/8.suppl_e.57.

Antibacterial activity of a monocyclic beta-lactam SQ 26,776.

J Antimicrob Chemother. 1981 Dec;8 Suppl E:111-22. doi: 10.1093/jac/8.suppl_e.111.

In-vitro studies on SQ 26,776, a new monobactam antibiotic.

J Antimicrob Chemother. 1981 Dec;8 Suppl E:81-8. doi: 10.1093/jac/8.suppl_e.81.

SQ 26,776, a novel beta-lactam: an in-vitro comparison with other antimicrobial agents.

J Antimicrob Chemother. 1981 Dec;8 Suppl E:39-47. doi: 10.1093/jac/8.suppl_e.39.

SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases.

J Antimicrob Chemother. 1981 Dec;8 Suppl E:103-10. doi: 10.1093/jac/8.suppl_e.103.

Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.

J Antimicrob Chemother. 1980 Mar;6(2):197-206. doi: 10.1093/jac/6.2.197.

Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamases.

J Antimicrob Chemother. 1985 Jun;15 Suppl C:15-23. doi: 10.1093/jac/15.suppl_c.15.

[In vitro activity of azthreonam (SQ 26.776) against Gram-negative bacteria].

Med Clin (Barc). 1984 Jan 28;82(3):106-9.

引用本文的文献

Derivation of a Precise and Consistent Timeline for Antibiotic Development.

Antibiotics (Basel). 2022 Sep 12;11(9):1237. doi: 10.3390/antibiotics11091237.

Combination effect of azthreonam with four aminoglycosides on nosocomial gram-positive cocci and non-fermenting gram-negative bacteria.

Eur J Clin Microbiol. 1982 Dec;1(6):371-4. doi: 10.1007/BF02019937.

In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis.

Antimicrob Agents Chemother. 1984 Feb;25(2):279-80. doi: 10.1128/AAC.25.2.279.

A case of recurrent salmonella septicaemia in an infant.

Postgrad Med J. 1984 Aug;60(706):546-8. doi: 10.1136/pgmj.60.706.546.

In vitro activity of azthreonam and Ro 17-2301 against multiresistant Pseudomonas aeruginosa strains.

Eur J Clin Microbiol. 1985 Feb;4(1):71-2. doi: 10.1007/BF02148669.

Aztreonam treatment of gram-negative septicemia.

Antimicrob Agents Chemother. 1986 Feb;29(2):359-61. doi: 10.1128/AAC.29.2.359.

Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Drugs. 1986 Feb;31(2):96-130. doi: 10.2165/00003495-198631020-00002.

Treatment of uncomplicated gonorrhoea with single dose aztreonam.

Genitourin Med. 1986 Oct;62(5):318-20. doi: 10.1136/sti.62.5.318.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验